Update on opportunistic infections.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D015658:HIV Infections / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications / Q000821:virology; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D018410:Pneumonia, Bacterial / Q000150:complications / Q000517:prevention & control; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents